Our firm represented GamidaCell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, in a $40 million private financing. For more information, click here.
Representation of NeuroDerm (Nasdaq: NDRM) which was acquired by Mitsubishi Tanabe Pharma for $1.1 billion! Our firm was proud to be part of the largest acquisition of an Israeli pharmaceuticals company. For more information, click here.
Our firm represented SimilarWeb, a leader in the digital market intelligence industry, in a $47 million financing round. For more information, click here.
Our firm represented JFrog in its acquisition of CloudMunch, a DevOps intelligence platform – their third acquisition during the last year. For more information click here.
Our firm represented Teddy Sagi in the purchase of RevelanTech by his German company Galipsa.
For more information (Hebrew), click here.
Representation of Armis, an Enterprise IoT security platform developer, in a $17 million funding round.
For more information, click here.
Our firm represented Hexadite in its acquisition by Microsoft. Hexadite is an Israeli cybersecurity company with a fully automated incident response solution. The acquisition will allow Microsoft to deliver a new generation of security capabilities to its Windows 10 clients. Read more here.
